July 16, 2026
Now available LUMVOA
LUMVOA (veligrotug-vvze) injection, for intravenous use, is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of thyroid eye disease regardless of thyroid eye disease activity or duration.
Please see full prescribing information.
